Zorzino L - Search Results

1

International study on inter-reader variability for circulating tumor cells in breast cancer.

Ignatiadis M, Riethdorf S, Bidard FC, Vaucher I, Khazour M, Rothé F, Metallo J, Rouas G, Payne RE, Coombes R, Teufel I, Andergassen U, Apostolaki S, Politaki E, Mavroudis D, Bessi S, Pestrin M, Di Leo A, Campion M, Reinholz M, Perez E, Piccart M, Borgen E, Naume B, Jimenez J, Aura C, Zorzino L, Cassatella M, Sandri M, Mostert B, Sleijfer S, Kraan J, Janni W, Fehm T, Rack B, Terstappen L, Repollet M, Pierga JY, Miller C, Sotiriou C, Michiels S, Pantel K. Ignatiadis M, et al. Among authors: zorzino l. Breast Cancer Res. 2014 Apr 23;16(2):R43. doi: 10.1186/bcr3647. Breast Cancer Res. 2014. PMID: 24758318 Free PMC article.

2

Serum levels of HER2 ECD can determine the response rate to low dose oral cyclophosphamide and methotrexate in patients with advanced stage breast carcinoma.

Sandri MT, Johansson H, Colleoni M, Zorzino L, Passerini R, Orlando L, Viale G. Sandri MT, et al. Among authors: zorzino l. Anticancer Res. 2004 Mar-Apr;24(2C):1261-6. Anticancer Res. 2004. PMID: 15154657 Free article. Clinical Trial.

3

Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy.

Sandri MT, Johansson HA, Zorzino L, Salvatici M, Passerini R, Maisonneuve P, Rocca A, Peruzzotti G, Colleoni M. Sandri MT, et al. Among authors: zorzino l. Cancer. 2007 Aug 1;110(3):509-17. doi: 10.1002/cncr.22825. Cancer. 2007. PMID: 17559147 Free article. Clinical Trial.

4

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications.

Nolé F, Munzone E, Zorzino L, Minchella I, Salvatici M, Botteri E, Medici M, Verri E, Adamoli L, Rotmensz N, Goldhirsch A, Sandri MT. Nolé F, et al. Among authors: zorzino l. Ann Oncol. 2008 May;19(5):891-7. doi: 10.1093/annonc/mdm558. Epub 2007 Dec 4. Ann Oncol. 2008. PMID: 18056915 Free article.

5

Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.

Botteri E, Sandri MT, Bagnardi V, Munzone E, Zorzino L, Rotmensz N, Casadio C, Cassatella MC, Esposito A, Curigliano G, Salvatici M, Verri E, Adamoli L, Goldhirsch A, Nolè F. Botteri E, et al. Among authors: zorzino l. Breast Cancer Res Treat. 2010 Jul;122(1):211-7. doi: 10.1007/s10549-009-0668-7. Epub 2009 Dec 6. Breast Cancer Res Treat. 2010. PMID: 19967556

6

Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery.

Sandri MT, Zorzino L, Cassatella MC, Bassi F, Luini A, Casadio C, Botteri E, Rotmensz N, Adamoli L, Nolè F. Sandri MT, et al. Among authors: zorzino l. Ann Surg Oncol. 2010 Jun;17(6):1539-45. doi: 10.1245/s10434-010-0918-2. Epub 2010 Feb 5. Ann Surg Oncol. 2010. PMID: 20135356

7

Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.

Munzone E, Nolé F, Goldhirsch A, Botteri E, Esposito A, Zorzino L, Curigliano G, Minchella I, Adamoli L, Cassatella MC, Casadio C, Sandri MT. Munzone E, et al. Among authors: zorzino l. Clin Breast Cancer. 2010 Oct 1;10(5):392-7. doi: 10.3816/CBC.2010.n.052. Clin Breast Cancer. 2010. PMID: 20920984

8

External quality assurance of circulating tumor cell enumeration using the CellSearch(®) system: a feasibility study.

Kraan J, Sleijfer S, Strijbos MH, Ignatiadis M, Peeters D, Pierga JY, Farace F, Riethdorf S, Fehm T, Zorzino L, Tibbe AG, Maestro M, Gisbert-Criado R, Denton G, de Bono JS, Dive C, Foekens JA, Gratama JW. Kraan J, et al. Among authors: zorzino l. Cytometry B Clin Cytom. 2011 Mar;80(2):112-8. doi: 10.1002/cyto.b.20573. Epub 2010 Nov 10. Cytometry B Clin Cytom. 2011. PMID: 21337491 Free article.

9

Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients.

Gervasoni A, Sandri MT, Nascimbeni R, Zorzino L, Cassatella MC, Baglioni L, Panigara S, Gervasi M, Di Lorenzo D, Parolini O. Gervasoni A, et al. Among authors: zorzino l. Oncol Rep. 2011 Jun;25(6):1669-703. doi: 10.3892/or.2011.1231. Epub 2011 Mar 23. Oncol Rep. 2011. PMID: 21455578

10

Prognostic role of CA15.3 in 7942 patients with operable breast cancer.

Sandri MT, Salvatici M, Botteri E, Passerini R, Zorzino L, Rotmensz N, Luini A, Mauro C, Bagnardi V, Cassatella MC, Bottari F, Casadio C, Colleoni M. Sandri MT, et al. Among authors: zorzino l. Breast Cancer Res Treat. 2012 Feb;132(1):317-26. doi: 10.1007/s10549-011-1863-x. Epub 2011 Nov 9. Breast Cancer Res Treat. 2012. PMID: 22065291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page